[1] |
张如霖,王弘明,彭霞,等. 血清淀粉样蛋白A、胱抑素C与尿白蛋白/肌酐比值联合检测在早期糖尿病肾病中的诊断价值[J]. 检验医学,2018,33(2):97-100.
|
[2] |
GAO P,XU B,SONG P,et al. The kidney specific protein myo-inositol oxygenase,a potential biomarker for diabetic nephropathy[J]. Kidney Blood Press Res,2018,43(6):1772-1785.
|
[3] |
KARALLIEDDE J,GNUDI L.Diabetes mellitus,a complex and heterogeneous disease,and the role of insulin resistance as a determinant of diabetic kidney disease[J]. Nephrol Dial Transplant,2016,31(2):206-213.
|
[4] |
KÖNINGER A,MATHAN A,MACH P,et al. Is afamin a novel biomarker for gestational diabetes mellitus? A pilot study[J]. Reprod Biol Endocrinol,2018,16(1):30.
|
[5] |
YANG C,DEMARS K M,CANDELARIO-JALIL E.Age-dependent decrease in adropin is associated with reduced levels of endothelial nitric oxide synthase and increased oxidative stress in the rat brain[J]. Aging Dis,2018,9(2):322-330.
|
[6] |
YOSAEE S,KHODADOST M,ESTEGHAMATI A,et al.Metabolic syndrome patients have lower levels of adropin when compared with healthy overweight/obese and lean subjects[J]. Am J Mens Health,2017,11(2):426-434.
|
[7] |
World Health Orgnization.Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia:report of a WHO/IDF consultation[M]. Geneva:WHO Document Production Services,2006.
|
[8] |
STEVENS P E,LEVIN A,Kidney Disease:Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease:improving global outcomes 2012 clinical practice guideline[J]. Ann Intern Med,2013,158(11):825-830.
|
[9] |
张丽. 晨尿尿蛋白/尿肌酐比值和24 h尿蛋白定量检测在糖尿病肾病中的应用[J]. 检验医学,2013,28(7):605.
|
[10] |
王恺隽,李铁威,王棕健,等. 高敏心肌肌钙蛋白T与冠状动脉粥样硬化特征的相关性[J]. 检验医学,2019,34(1):11-18.
|
[11] |
ALICIC R Z,ROONEY M,TUTTLE K R.Diabetic kidney disease:challenges,progress,and possibilities[J]. Clin J Am Soc Nephrol,2017,12(12):2032-2045.
|
[12] |
YANG D,LIVINGSTON M J,LIU Z,et al.Autophagy in diabetic kidney disease:regulation,pathological role and therapeutic potential[J]. Cell Mol Life Sci,2018,75(4):669-688.
|
[13] |
TRAMONTANA A,DIEPLINGER B,STANGL G,et al.First trimester serum afamin concentrations are associated with the development of pre-eclampsia and gestational diabetes mellitus in pregnant women[J]. Clin Chim Acta,2018,476:160-166.
|
[14] |
KRONENBERG F,KOLLERITS B,KIECHL S,et al.Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome[J]. Circ Cardiovasc Genet,2014,7(6):822-829.
|
[15] |
KOLLERITS B,LAMINA C,HUTH C,et al.Plasma concentrations of afamin are associated with prevalent and incident type 2 diabetes:a pooled analysis in more than20 000 individuals[J]. Diabetes Care,2017,40(10):1386-1393.
|
[16] |
KABURAGI Y,TAKAHASHI E,KAJIO H,et al.Urinary afamin levels are associated with the progression of diabetic nephropathy[J]. Diabetes Res Clin Pract,2019,147:37-46.
|
[17] |
BOLAYIR H A,KIVRAK T,GUNES H,et al.Adropin and circadian variation of blood pressure[J]. Kardiol Pol,2018,76(4):776-782.
|
[18] |
MARCZUK N,CECERSKA-HERYĆ E,JESIONOWSKA A,et al.Adropin-physiological and pathophysiological role[J]. Postepy Hig Med Dosw(Online),2016,70:981-988.
|
[19] |
HU W,CHEN L.Association of serum adropin concentrations with diabetic nephropathy[J]. Mediators Inflamm,2016,2016:6038261.
|
[20] |
CHOI H N,YIM J E.Plasma adropin as a potential marker predicting obesity and obesity-associated cancer in Korean patients with type 2 diabetes mellitus[J]. J Cancer Prev,2018,23(4):191-196.
|